The MAV data released today was truly superb. The 3.5million was much more than the 1 to 2.5 million street estimate and considerably more than the 1.4 million of March. The results are especially relevant because it reduces the CVS-Caremark anticipated effect and permits SCRC to draw down more of its 4 million credit line. Most important as you stated, the bottom line will be greatly improved by the new efficiencies put into place. In previous months, the co. had produced an 8 to 10% margin. I now look for at least a 15% margin. Its a wonderful way to start the second quarter. Bob and his team deserve our praises for one 'Helluva job!